During the past decade, Smilow Cancer Hospital-Torrington Care Center conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 19 clinical trials were completed, i.e. on average, 35.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 14 clinical trials were completed. i.e. 73.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Smilow Cancer Hospital-Torrington Care Center" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Smilow Cancer Hospital-Torrington Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital-Torrington Care Center" are "HER2/Neu Negative" (5 trials), "Breast Adenocarcinoma" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials) and "Stage III Breast Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Smilow Cancer Hospital-Torrington Care Center" in a lesser frequency.

Most popular intervention types in "Smilow Cancer Hospital-Torrington Care Center" are "Drug" (57 trials), "Other" (47 trials), "Biological" (34 trials), "Procedure" (20 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (23 trials), "Computed Tomography" (16 trials), "Biospecimen Collection" (13 trials) and "Questionnaire Administration" (13 trials). Other intervention names were less common.

The vast majority of trials in "Smilow Cancer Hospital-Torrington Care Center" are 54 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Smilow Cancer Hospital-Torrington Care Center". undefined are not yet recruiting, 19 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Smilow Cancer Hospital-Torrington Care Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Smilow Cancer Hospital-Torrington Care Center, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".